Literature DB >> 8385271

Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch.

L Ruel1, M Bourouis, P Heitzler, V Pantesco, P Simpson.   

Abstract

During neurogenesis in Drosophila, groups of equipotential, neurally competent cells choose between epidermal and neural fates. Notch, a phylogenetically conserved transmembrane protein, may act as a receptor in a lateral signalling pathway in which a single neural precursor is chosen from each group and the neural fate of the other cells is inhibited, causing them to differentiate into epidermis. Possible intracellular transduction events mediating signals from Notch are, however, unknown. shaggy is also required for the lateral signal and encodes serine/threonine protein kinases with homology to the glycogen synthase kinase-3 (GSK-3) enzymes that act in signal transduction pathways in vertebrates. We report here that, in transgenic flies, GSK-3 beta can substitute for shaggy, and we also present a study of epistatic relationships between shaggy and gain and loss of function alleles of Notch. The results indicate that shaggy/GSK-3 is part of a signalling pathway downstream of Notch.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385271     DOI: 10.1038/362557a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  54 in total

1.  Notch and wingless regulate expression of cuticle patterning genes.

Authors:  C S Wesley
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Drosophila caspase transduces Shaggy/GSK-3beta kinase activity in neural precursor development.

Authors:  Hirotaka Kanuka; Erina Kuranaga; Kiwamu Takemoto; Tetsuo Hiratou; Hideyuki Okano; Masayuki Miura
Journal:  EMBO J       Date:  2005-10-13       Impact factor: 11.598

3.  Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines.

Authors:  Bradley W Doble; Satish Patel; Geoffrey A Wood; Lisa K Kockeritz; James R Woodgett
Journal:  Dev Cell       Date:  2007-06       Impact factor: 12.270

Review 4.  Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes.

Authors:  Katrina MacAulay; James R Woodgett
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

5.  Arabidopsis homologs of the shaggy and GSK-3 protein kinases: molecular cloning and functional expression in Escherichia coli.

Authors:  M W Bianchi; D Guivarc'h; M Thomas; J R Woodgett; M Kreis
Journal:  Mol Gen Genet       Date:  1994-02

Review 6.  Signal transduction by the Wnt family of ligands.

Authors:  T C Dale
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

Review 7.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

8.  Glycogen synthase kinase (GSK) 3 in pregnancy and parturition: a systematic review of literature.

Authors:  Narmada Lavu; Lauren Richardson; Elizabeth Bonney; Ramkumar Menon
Journal:  J Matern Fetal Neonatal Med       Date:  2019-01-06

9.  Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease.

Authors:  Oyinkan Sofola; Fiona Kerr; Iain Rogers; Richard Killick; Hrvoje Augustin; Carina Gandy; Marcus J Allen; John Hardy; Simon Lovestone; Linda Partridge
Journal:  PLoS Genet       Date:  2010-09-02       Impact factor: 5.917

10.  Functional studies of shaggy/glycogen synthase kinase 3 phosphorylation sites in Drosophila melanogaster.

Authors:  Deppie Papadopoulou; Michele Wolfe Bianchi; Marc Bourouis
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.